The spike protein of the severe acute respiratory syndrome coronavirus (SARS-CoV) mediates cell fusion by binding to target cell surface receptors. This paper reports a simple method for dissecting the viral protein and for searching for foldable fragments in a random but systematic manner. The method involves digestion by DNase I to generate a pool of short DNA segments, followed by an additional step of reassembly of these segments to produce a library of DNA fragments with random ends but controllable lengths. To rapidly screen for discrete folded polypeptide fragments, the reassembled gene fragments were further cloned into a vector as N-terminal fusions to a folding reporter gene which was a variant of green fluorescent protein. Two foldable fragments were identified for the SARS-CoV spike protein, which coincide with various anti-SARS peptides derived from the hepated repeat (HR) region 2 of the spike protein. The method should be applicable to other viral proteins to isolate antigen or vaccine candidates, thus providing an alternative to the full-length proteins (subunits) or linear short peptides.
Severe acute respiratory syndrome coronavirus (SARS-CoV), which is the causative agent of the atypical pneumonia, was first identified in the fall of 2002 to be a previously unknown member of the family of coronaviruses
The green fluorescent protein (GFP) gene was amplified from an in-house GFP-containing vector pET30a-
The SARS-CoV spike gene was obtained from the Huada Beijing Genomics Institute. Fragmentation and re-assembly of the target gene were performed as described by Lorimer and Pastan
Transformed
Saturated overnight cultures were diluted 100-fold into LB medium containing 50 μg/mL kanamycin and grown at 37°C for about 2 h to reach an optical density at 600 nm (OD600) of 0.5-0.6. Protein expression was initiated with 0.2 mmol/L of IPTG, and continued for 4 h at 23°C. Cells were then collected and lysed for soluble protein extraction. The supernatant fractions (soluble protein) and cell pellets (insoluble protein) were resolved by SDS-PAGE using a 12% acrylamide gel.
This work sought to identify smaller but folded SARS-CoV spike fragments for use as possible antigen or vaccine candidates. Compared with linear short peptides derived from the protein, folded fragments may be advantageous as they have the potential to provide discontinuous epitopes. The SARS-CoV spike gene was digested by DNase I to generate a pool of short DNA segments, followed by an additional step of reassembly of these segments to produce a library of DNA fragments with random ends Expression construct (pET30a-linker-GFP). The sequence is flanked by the
Among about 4300 clones screened, 230 clones were found to be fluorescent (see Expression of fusion proteins (a) Colonies obtained from inserting and expression of SARS-CoV spike gene fragments in pET30a-linker-GFP using
Widely disparate virus families have been shown to contain two hepated repeat (HR) regions, which play a critical role in viral fusion with the target cell Sequence analysis (a) CLUSTALW alignment of ssPtu-15 and ssPtu-16 with HR2 derived peptides which interfere with SARS-CoV S-mediated fusion to host cells: peptide CP-1
Several studies
In summary, the dissection approach described in this study has the potential to produce foldable fragments of viral surface proteins that may be useful for the design of antiviral compounds and provide alternative antigen or vaccine candidates. The method is target protein independent and thus can be applied to various viral proteins. The process is also simple and rapid. The method should be applicable for dissecting and understanding other non-viral proteins, for example, to identify smaller polypeptide units that are structurally, functionally, or evolutionally relevant.
The authors thank Dr. K. Kohno and Dr. X. Xing for the GFP gene and the Huada Beijing Genomics Institute and Dr. Y. Ruo for the SARS-CoV spike gene.
Supported by the Tsinghua University SARS Special Fund and the National Key Basic Research and Development (973) Program of China (No. 2003CB716002)